Cargando…

Crystal structures of (η(4)-cyclo­octa-1,5-diene)bis(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide and (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide

The title complexes, (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide, [Ir(C(5)H(8)N(2))(2)(C(8)H(12))]I, (1) and (η(4)-cyclo­octa-1,5-di­ene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide, [Ir(C(7)H(12)N(2))(2)(C(8)H(12))]I, (2), were prepared using a mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernier, Chad M., DuChane, Christine M., Merola, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199247/
https://www.ncbi.nlm.nih.gov/pubmed/32431918
http://dx.doi.org/10.1107/S2056989020004235
_version_ 1783529118584799232
author Bernier, Chad M.
DuChane, Christine M.
Merola, Joseph S.
author_facet Bernier, Chad M.
DuChane, Christine M.
Merola, Joseph S.
author_sort Bernier, Chad M.
collection PubMed
description The title complexes, (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide, [Ir(C(5)H(8)N(2))(2)(C(8)H(12))]I, (1) and (η(4)-cyclo­octa-1,5-di­ene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide, [Ir(C(7)H(12)N(2))(2)(C(8)H(12))]I, (2), were prepared using a modified literature method. After carrying out the oxidative addition of the amino acid l-proline to [Ir(COD)(IMe)(2)]I in water and slowly cooling the reaction to room temperature, a suitable crystal of 1 was obtained and analyzed by single-crystal X-ray diffraction at 100 K. Although this crystal structure has previously been reported in the Pbam space group, it was highly disordered and precise atomic coordinates were not calculated. A single crystal of 2 was also obtained by heating the complex in water and letting it slowly cool to room temperature. Complex 1 was found to crystallize in the monoclinic space group C2/m, while 2 crystallizes in the ortho­rhom­bic space group Pccn, both with Z = 4.
format Online
Article
Text
id pubmed-7199247
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-71992472020-05-19 Crystal structures of (η(4)-cyclo­octa-1,5-diene)bis(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide and (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide Bernier, Chad M. DuChane, Christine M. Merola, Joseph S. Acta Crystallogr E Crystallogr Commun Research Communications The title complexes, (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide, [Ir(C(5)H(8)N(2))(2)(C(8)H(12))]I, (1) and (η(4)-cyclo­octa-1,5-di­ene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide, [Ir(C(7)H(12)N(2))(2)(C(8)H(12))]I, (2), were prepared using a modified literature method. After carrying out the oxidative addition of the amino acid l-proline to [Ir(COD)(IMe)(2)]I in water and slowly cooling the reaction to room temperature, a suitable crystal of 1 was obtained and analyzed by single-crystal X-ray diffraction at 100 K. Although this crystal structure has previously been reported in the Pbam space group, it was highly disordered and precise atomic coordinates were not calculated. A single crystal of 2 was also obtained by heating the complex in water and letting it slowly cool to room temperature. Complex 1 was found to crystallize in the monoclinic space group C2/m, while 2 crystallizes in the ortho­rhom­bic space group Pccn, both with Z = 4. International Union of Crystallography 2020-04-03 /pmc/articles/PMC7199247/ /pubmed/32431918 http://dx.doi.org/10.1107/S2056989020004235 Text en © Bernier et al. 2020 http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/4.0/
spellingShingle Research Communications
Bernier, Chad M.
DuChane, Christine M.
Merola, Joseph S.
Crystal structures of (η(4)-cyclo­octa-1,5-diene)bis(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide and (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide
title Crystal structures of (η(4)-cyclo­octa-1,5-diene)bis(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide and (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide
title_full Crystal structures of (η(4)-cyclo­octa-1,5-diene)bis(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide and (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide
title_fullStr Crystal structures of (η(4)-cyclo­octa-1,5-diene)bis(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide and (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide
title_full_unstemmed Crystal structures of (η(4)-cyclo­octa-1,5-diene)bis(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide and (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide
title_short Crystal structures of (η(4)-cyclo­octa-1,5-diene)bis(1,3-di­methyl­imidazol-2-yl­idene)iridium(I) iodide and (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(I) iodide
title_sort crystal structures of (η(4)-cyclo­octa-1,5-diene)bis(1,3-di­methyl­imidazol-2-yl­idene)iridium(i) iodide and (η(4)-cyclo­octa-1,5-diene)bis­(1,3-di­ethyl­imidazol-2-yl­idene)iridium(i) iodide
topic Research Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199247/
https://www.ncbi.nlm.nih.gov/pubmed/32431918
http://dx.doi.org/10.1107/S2056989020004235
work_keys_str_mv AT bernierchadm crystalstructuresofē4cycloocta15dienebis13dimethylimidazol2ylideneiridiumiiodideandē4cycloocta15dienebis13diethylimidazol2ylideneiridiumiiodide
AT duchanechristinem crystalstructuresofē4cycloocta15dienebis13dimethylimidazol2ylideneiridiumiiodideandē4cycloocta15dienebis13diethylimidazol2ylideneiridiumiiodide
AT merolajosephs crystalstructuresofē4cycloocta15dienebis13dimethylimidazol2ylideneiridiumiiodideandē4cycloocta15dienebis13diethylimidazol2ylideneiridiumiiodide